{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:36:16Z","timestamp":1792712176179,"version":"4.5.0"},"reference-count":112,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although measurement of thyroid hormones (THs), TSH and thyroid autoantibodies, is usually straightforward, erroneous results are occasionally generated, raising the possibility of incorrect or delayed diagnoses, unwarranted investigations, and provision of inappropriate treatments. Assay interference can be acquired (e.g. antibodies), genetic (e.g. variant TH-binding proteins), or pharmaceutical (e.g. displacing agents and biotin) in nature. In those with discordant thyroid function, assay interference must be excluded prior to the diagnosis of rare inherited (resistance to thyroid hormone) or tumoural conditions (TSHoma). Liaison between the clinician and clinical biochemistry teams is essential when assay interference is being investigated; appropriate further biochemical testing depends on the clinical picture, initial biochemistry, and local biochemical expertise. In a subset of cases, access to a regional centre where patients can be clinically assessed, in conjunction with performance of specialised clinical laboratory testing (biochemical, +\/\u2212 genetic), may be required. When assay interference is identified, clear communication with the patient (ideally aided by reliable, accessible patient literature) and documentation to their physician are necessary. Professionals must stay updated on advances in testing and be alert for evolving assay interferences. An accompanying plain language summary is intended to provide an accessible overview of the key messages and recommendations contained in this guideline for non-specialist readers, including patients, carers, healthcare professionals outside the speciality, and the wider public.<\/jats:p>","DOI":"10.1530\/etj-26-0011","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:17:54Z","timestamp":1784287074000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":2,"title":["2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function"],"prefix":"10.1530","volume":"15","author":[{"given":"Irene","family":"Campi","sequence":"first","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Copenhagen University Hospital, Rigshospitalet 2 , ,","place":["Copenhagen, Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen 3 , ,","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gruson","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Cliniques Universitaires St-Luc, UC Louvain 4 , ,","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Halsall","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust 5 , ,","place":["Cambridge, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-1271","authenticated-orcid":true,"given":"Veronique","family":"Raverot","sequence":"additional","affiliation":[{"name":"Service de Biochimie et Biologie Mol\u00e9culaire, Laboratoire de Biologie M\u00e9dicale Multi-Sites (LBMMS), Hospices Civils de Lyon 6 , ,","place":["Lyon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center Rotterdam 7 , ,","place":["Rotterdam, Netherlands"]},{"name":"Department of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam 8 , ,","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7318-7166","authenticated-orcid":true,"given":"Carla","family":"Moran","sequence":"additional","affiliation":[{"name":"Endocrine Section, Beacon Hospital 9 , ,","place":["Dublin, Ireland"]},{"name":"Endocrinology Department, St Vincent\u2019s University Hospital 10 , ,","place":["Dublin, Ireland"]},{"name":"UCD School of Medicine, Health Sciences Centre 11 , ,","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026081413265448000_bib1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"2026081413265448000_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib3","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026081413265448000_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2023.0169","article-title":"Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status","volume":"33","author":"Van Uytfanghe","year":"2023","journal-title":"Thyroid"},{"key":"2026081413265448000_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.beem.2013.10.003","article-title":"Pitfalls in the measurement and interpretation of thyroid function tests","volume":"27","author":"Koulouri","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026081413265448000_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/er.2018-00119","article-title":"Interferences with thyroid function immunoassays: clinical implications and detection algorithm","volume":"39","author":"Favresse","year":"2018","journal-title":"Endocr Rev"},{"key":"2026081413265448000_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026081413265448000_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2015.09.002","article-title":"Inherited defects of thyroxine-binding proteins","volume":"29","author":"Pappa","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026081413265448000_bib9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1210\/clinem\/dgad681","article-title":"Approach to the patient with raised thyroid hormones and nonsuppressed TSH","volume":"109","author":"Moran","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/thy.2022.0397","article-title":"Laboratory thyroid tests: a historical perspective","volume":"33","author":"Spencer","year":"2023","journal-title":"Thyroid"},{"key":"2026081413265448000_bib11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1373\/clinchem.2016.269456","article-title":"Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval","volume":"63","author":"Thienpont","year":"2017","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib12","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1515\/cclm-2017-1027","article-title":"Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests","volume":"56","author":"Favresse","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-15-0883","article-title":"Variability in the detection of macro TSH in different immunoassay systems","volume":"174","author":"Hattori","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026081413265448000_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000509184","article-title":"Macro-TSH: a diagnostic challenge","volume":"10","author":"Larsen","year":"2021","journal-title":"Eur Thyroid J"},{"key":"2026081413265448000_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/thy.2022.0457","article-title":"Prevalence and pathogenesis of macro-thyrotropin in neonates: analysis of umbilical cord blood from 939 neonates and their mothers","volume":"33","author":"Hattori","year":"2023","journal-title":"Thyroid"},{"key":"2026081413265448000_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1515\/cclm-2023-1184","article-title":"Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee","volume":"62","author":"van der Molen","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib17","article-title":"Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays","volume":"121\u2013122","author":"Galior","year":"2023","journal-title":"Clin Biochem"},{"key":"2026081413265448000_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/cen.15179","article-title":"PEG precipitation to detect macro-TSH in clinical practice: a systematic review","volume":"102","author":"Piticchio","year":"2025","journal-title":"Clin Endocrinol"},{"key":"2026081413265448000_bib19","article-title":"Large method differences for free thyroid hormone assays in the hyperthyroid range can affect assessment of hyperthyroid status: Comparison of Abbott Alinity to Roche Cobas, Siemens Centaur and equilibrium dialysis LC-MS\/MS","volume":"121\u2013122","author":"Westbye","year":"2023","journal-title":"Clin Biochem"},{"key":"2026081413265448000_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/edrv-10-3-275","article-title":"Inherited thyroxine-binding globulin abnormalities in man","volume":"10","author":"Refetoff","year":"1989","journal-title":"Endocr Rev"},{"key":"2026081413265448000_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1994.tb02558.x","article-title":"Prevalence of thyroid hormone autoantibodies in healthy subjects","volume":"41","author":"Sakata","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2026081413265448000_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/clinchem\/29.6.1324","article-title":"Interference in radioimmunoassay of total serum thyroxin and free thyroxin due to thyroxin-binding autoantibodies","volume":"29","author":"Bhagat","year":"1983","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib23","volume-title":"Endotext","author":"Spencer","year":"2017"},{"key":"2026081413265448000_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24124","article-title":"High prevalence of thyroid hormone autoantibody and low rate of thyroid hormone detection interference","volume":"36","author":"Ni","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"2026081413265448000_bib25","first-page":"139","article-title":"Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays","volume":"45","author":"Sapin","year":"1996","journal-title":"Horm Res"},{"key":"2026081413265448000_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/10507256251364557","article-title":"Variable diagnoses in cases referred for discordant thyroid function tests: focus on lymphoproliferative disorders","volume":"35","author":"Musolino","year":"2025","journal-title":"Thyroid"},{"key":"2026081413265448000_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1515\/cclm-2022-1134","article-title":"Description and validation of an equilibrium dialysis ID-LC-MS\/MS candidate reference measurement procedure for free thyroxine in human serum","volume":"61","author":"Jansen","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib28","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jalm\/jfac010","article-title":"Clinical utility and analytical aspects of direct measurements of free hormones using mass spectrometry-based methods","volume":"7","author":"Kushnir","year":"2022","journal-title":"J Appl Lab Med"},{"key":"2026081413265448000_bib29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1515\/CCLM.2011.639","article-title":"IFCC international conventional reference procedure for the measurement of free thyroxine in serum: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group for Standardization of Thyroid Function Tests (WG-STFT)","volume":"49","author":"Van Houcke","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clinbiochem.2023.03.010","article-title":"Development of an equilibrium dialysis ID-UPLC-MS\/MS candidate reference measurement procedure for free thyroxine in human serum","volume":"116","author":"Ribera","year":"2023","journal-title":"Clin Biochem"},{"key":"2026081413265448000_bib31","first-page":"109","article-title":"Assessment of thyroid function: towards an integrated laboratory \u2013 clinical approach","volume":"24","author":"Stockigt","year":"2003","journal-title":"Clin Biochem Rev"},{"key":"2026081413265448000_bib32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/jcem-65-6-1259","article-title":"Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma","volume":"65","author":"Mendel","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib33","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0145","article-title":"Pregnancy disrupts the accuracy of automated fT4 immunoassays","volume":"11","author":"Jansen","year":"2022","journal-title":"Eur Thyroid J"},{"key":"2026081413265448000_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-19-1021","article-title":"Familial dysalbuminaemic hyperthyroxinaemia interferes with current free thyroid hormone immunoassay methods","volume":"182","author":"Khoo","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2026081413265448000_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/thy.2019.0058","article-title":"Free thyroxine concentrations in sera of individuals with familial dysalbuminemic hyperthyroxinemia: comparison of three methods of measurement","volume":"30","author":"Refetoff","year":"2020","journal-title":"Thyroid"},{"key":"2026081413265448000_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1515\/jpem-2014-0019","article-title":"Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading","volume":"28","author":"Choudhary","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026081413265448000_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117706","article-title":"Interference against a newly labeled substance with ruthenium sulfonate complexes showing discrepant thyroid function test results","volume":"553","author":"Takahashi","year":"2024","journal-title":"Clin Chim Acta"},{"key":"2026081413265448000_bib38","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.3390\/cimb45110549","article-title":"An analysis of the Biotin-(Strept)avidin system in immunoassays: interference and mitigation strategies","volume":"45","author":"Balzer","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"2026081413265448000_bib39","first-page":"1361","article-title":"Fatty acid-induced increase in serum dialyzable free thyroxine after physical exercise: implication for nonthyroidal illness","volume":"74","author":"Liewendahl","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib40","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1210\/jcem-63-6-1394","article-title":"Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin","volume":"63","author":"Mendel","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10408363.2022.2121960","article-title":"Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization","volume":"60","author":"D\u2019Aurizio","year":"2023","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2026081413265448000_bib42","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0088","article-title":"Thyroid function tests, incongruent internally and with thyroid status, both in a pregnant woman and in her newborn daughter","volume":"11","author":"D\u2019Aurizio","year":"2022","journal-title":"Eur Thyroid J"},{"key":"2026081413265448000_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/clinchem\/36.3.457","article-title":"Differentiating various abnormalities of thyroxin binding to serum proteins by radioelectrophoresis of thyroxin and immunoassay of binding proteins","volume":"36","author":"Pandian","year":"1990","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1373\/clinchem.2009.140228","article-title":"Report of the IFCC working group for standardization of thyroid function tests; part 3: total thyroxine and total triiodothyronine","volume":"56","author":"Thienpont","year":"2010","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib45","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0041","article-title":"Neonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?","volume":"12","author":"Boelen","year":"2023","journal-title":"Eur Thyroid J"},{"key":"2026081413265448000_bib46","first-page":"142","article-title":"Positive interference in triiodothyronine (T3) assay using a radioimmunoassay kit","volume":"4","author":"Rezaei-Ghaleh","year":"2007","journal-title":"Int J Endocrinol Metab"},{"key":"2026081413265448000_bib47","first-page":"501","article-title":"A comparison of measurements of serum free T3 concentration by equilibrium dialysis, free T3 index, and T3:TBG ratio in thyroidal and non-thyroidal illnesses","volume":"103","author":"Konno","year":"1983","journal-title":"Acta Endocrinol"},{"key":"2026081413265448000_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/clinchem\/31.4.517","article-title":"Improved ultrafiltration method for simultaneous measurement of free thyroxin and free triiodothyronine in serum","volume":"31","author":"Wang","year":"1985","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/00365518609083686","article-title":"Ultrafiltration method for direct radioimmunoassay measurement of free thyroxine and free tri-iodothyronine in serum","volume":"46","author":"Weeke","year":"1986","journal-title":"Scand J Clin Lab Invest"},{"key":"2026081413265448000_bib50","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1373\/clinchem.2009.140194","article-title":"Report of the IFCC working group for standardization of thyroid function tests; part 2: free thyroxine and free triiodothyronine","volume":"56","author":"Thienpont","year":"2010","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib51","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.clinbiochem.2007.08.007","article-title":"Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry","volume":"40","author":"Gu","year":"2007","journal-title":"Clin Biochem"},{"key":"2026081413265448000_bib52","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/(SICI)1097-0231(19991015)13:19<1924::AID-RCM734>3.0.CO;2-U","article-title":"Isotope dilution-gas chromatography\/mass spectrometry and liquid chromatography\/electrospray ionization-tandem mass spectrometry for the determination of triiodo-L-thyronine in serum","volume":"13","author":"Thienpont","year":"1999","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2026081413265448000_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cccn.2004.01.007","article-title":"Isotope dilution tandem mass spectrometric method for T4\/T3","volume":"343","author":"Soukhova","year":"2004","journal-title":"Clinica Chim Acta"},{"key":"2026081413265448000_bib54","doi-asserted-by":"crossref","first-page":"E1381","DOI":"10.1210\/jc.2013-4077","article-title":"A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia","volume":"99","author":"Schoenmakers","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib55","first-page":"1448","article-title":"Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect","volume":"83","author":"Sunthornthepvarakul","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026081413265448000_bib57","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/clinchem\/45.7.942","article-title":"Human anti-animal antibody interferences in immunological assays","volume":"45","author":"Kricka","year":"1999","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1258\/acb.2010.010160","article-title":"Interference by antiruthenium antibodies in the Roche thyroid-stimulating hormone assay","volume":"48","author":"Buijs","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"2026081413265448000_bib59","article-title":"Factitiously elevated total triiodothyronine in a euthyroid patient with multiple myeloma","volume":"2021","author":"Mandal","year":"2021","journal-title":"Case Rep Endocrinol"},{"key":"2026081413265448000_bib60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/CCLM.2000.112","article-title":"Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference","volume":"38","author":"Martel","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ajcp\/aqab124","article-title":"Triiodothyroacetic acid cross-reacts with measurement of triiodothyronine (T3) on various immunoassay platforms","volume":"157","author":"Chan","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"2026081413265448000_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2015.12.008","article-title":"Diiodothyropropionic acid (DITPA) cross-reacts with thyroid function assays on different immunoassay platforms","volume":"453","author":"Leung","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2026081413265448000_bib63","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1089\/thy.2020.0866","article-title":"Biotin interference in assays for thyroid hormones, thyrotropin and thyroglobulin","volume":"31","author":"Ylli","year":"2021","journal-title":"Thyroid"},{"key":"2026081413265448000_bib64","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1373\/clinchem.2005.055400","article-title":"Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720","volume":"51","author":"Bowen","year":"2005","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib65","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1515\/cclm-2021-1211","article-title":"Dubiously increased FT4 and FT3 levels in clinically euthyroid patients: clinical finding or analytical pitfall?","volume":"60","author":"K\u00fclz","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib66","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1373\/clinchem.2005.052142","article-title":"Reason for limitations of heterophilic blocking tube use on certain beckman coulter access assays","volume":"51","author":"Cantor","year":"2005","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinchem\/30.1.28","article-title":"Effect of sample dilution on measurements of free (unbound) hormones","volume":"30","author":"Geiseler","year":"1984","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib68","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.37792","article-title":"Avoiding misdiagnosis due to antibody interference with serum free thyroxin","volume":"15","author":"Beato-V\u00edbora","year":"2016","journal-title":"Int J Endocrinol Metabol"},{"key":"2026081413265448000_bib69","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1515\/cclm-2014-0813","article-title":"Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges","volume":"53","author":"Giovanella","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib70","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.3390\/jcm13092463","article-title":"Diagnostic, Theranostic and prognostic value of thyroglobulin in thyroid cancer","volume":"13","author":"Giovanella","year":"2024","journal-title":"J Clin Med"},{"key":"2026081413265448000_bib71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr Rev"},{"key":"2026081413265448000_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","article-title":"Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of nuclear medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"2026081413265448000_bib73","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-14-0148","article-title":"Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper","volume":"171","author":"Giovanella","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2026081413265448000_bib74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5603\/EP.a2020.0079","article-title":"Laboratory interference in the thyroid function test","volume":"71","author":"Paczkowska","year":"2020","journal-title":"Endokrynol Pol"},{"key":"2026081413265448000_bib75","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cca.2014.10.035","article-title":"Thyroglobulin in differentiated thyroid cancer","volume":"444","author":"Evans","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026081413265448000_bib76","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac169","article-title":"Thyroglobulin assay interferences: clinical usefulness of mass-spectrometry methods","volume":"7","author":"Barbesino","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026081413265448000_bib77","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2310\/JIM.0b013e318276deb4","article-title":"A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies","volume":"60","author":"Clarke","year":"2012","journal-title":"J Invest Med"},{"key":"2026081413265448000_bib78","first-page":"343","article-title":"Human thyroglobulin reference material (CRM 457). 2nd part: physicochemical characterization and certification","volume":"54","author":"Feldt-Rasmussen","year":"1996","journal-title":"Ann Biol Clin"},{"key":"2026081413265448000_bib79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03350129","article-title":"European interlaboratory comparison of serum thyroglobulin measurement","volume":"11","author":"Feldt-Rasmussen","year":"1998","journal-title":"J Endocrinological Invest"},{"key":"2026081413265448000_bib80","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1210\/jc.2005-0671","article-title":"Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas","volume":"90","author":"Spencer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib81","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014178","article-title":"Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: a case report","volume":"98","author":"Lupoli","year":"2019","journal-title":"Medicine"},{"key":"2026081413265448000_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cca.2020.06.027","article-title":"Falsely decreased thyroglobulin levels in a patient with differentiated thyroid carcinoma","volume":"509","author":"Hillebrand","year":"2020","journal-title":"Clin Chim Acta"},{"key":"2026081413265448000_bib83","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1515\/cclm-2015-1161","article-title":"Calcitonin measurement and immunoassay interference: a case report and literature review","volume":"54","author":"Censi","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib84","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1515\/cclm-2015-0587","article-title":"Comparison of the Elecsys calcitonin assay with the Immulite 1000 assay. Describing one case with heterophilic antibody interference","volume":"54","author":"Bories","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib85","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/jc.2015-3137","article-title":"Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay","volume":"101","author":"Alves","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib86","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1515\/CCLM.2006.166","article-title":"Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb)","volume":"44","author":"Jensen","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib87","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2010.03831.x","article-title":"Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample","volume":"73","author":"Evans","year":"2010","journal-title":"Clin Endocrinol"},{"key":"2026081413265448000_bib88","article-title":"A novel bioassay for thyroid-blocking immunoglobulins","volume":"15","author":"George","year":"2014","journal-title":"Front Endocrinol"},{"key":"2026081413265448000_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1468768","article-title":"Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin","volume":"15","author":"Olivo","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026081413265448000_bib90","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2016-1971","article-title":"Factitious Graves\u2019 disease due to biotin immunoassay interference-a case and review of the literature","volume":"101","author":"Elston","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081413265448000_bib91","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.eprac.2024.10.007","article-title":"The complex web of interferences with thyroid function tests","volume":"31","author":"Al-Bahadili","year":"2025","journal-title":"Endocr Pract"},{"key":"2026081413265448000_bib92","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13317-017-0096-3","article-title":"Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry Guidelines: comparison of eleven different automated methods","volume":"8","author":"D\u2019Aurizio","year":"2017","journal-title":"Auto Immun Highlights"},{"key":"2026081413265448000_bib93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2265.1982.tb00712.x","article-title":"The acute changes in thyroid stimulating immunoglobulins, thyroglobulin and thyroglobulin antibodies following subtotal thyroidectomy","volume":"16","author":"Bech","year":"1982","journal-title":"Clin Endocrinol"},{"key":"2026081413265448000_bib94","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/BF03348564","article-title":"Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo","volume":"8","author":"Feldt-Rasmussen","year":"1985","journal-title":"J Endocrinological Invest"},{"key":"2026081413265448000_bib95","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/105072503322240013","article-title":"Thyroglobulin autoantibody levels below the cut-off for positivity can interfere with thyroglobulin measurement","volume":"13","author":"Cubero","year":"2003","journal-title":"Thyroid"},{"key":"2026081413265448000_bib96","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/labmed\/lmac013","article-title":"Value of thyroid peroxidase antibodies in neuroimmune diseases: analysis of interference during treatment with intravenous immunoglobulins","volume":"53","author":"Jim\u00e9nez-Legido","year":"2022","journal-title":"Lab Med"},{"key":"2026081413265448000_bib97","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.12688\/f1000research.11535.1","article-title":"Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity","volume":"6","author":"Bliddal","year":"2017","journal-title":"F1000Res"},{"key":"2026081413265448000_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2009.08.013","article-title":"Iodine intake as a determinant of thyroid disorders in populations","volume":"24","author":"Laurberg","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026081413265448000_bib99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cca.2015.10.025","article-title":"The upper reference limit for thyroid peroxidase autoantibodies is method-dependent: a collaborative study with biomedical industries","volume":"452","author":"Tozzoli","year":"2016","journal-title":"Clin Chim Acta"},{"key":"2026081413265448000_bib100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-3083.1997.d01-90.x","article-title":"Antibody reactivity against thyroid peroxidase and myeloperoxidase in autoimmune thyroiditis and systemic vasculitis","volume":"46","author":"Haapala","year":"2016","journal-title":"Scand J Immunol"},{"key":"2026081413265448000_bib101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000441-200102000-00001","article-title":"Absence of cross-reactivity to myeloperoxidase of anti-thyroid microsomal antibodies in patients with autoimmune thyroid diseases","volume":"321","author":"Freire","year":"2001","journal-title":"Am J Med Sci"},{"key":"2026081413265448000_bib102","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0125","article-title":"2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action","volume":"13","author":"Persani","year":"2024","journal-title":"Eur Thyroid J"},{"key":"2026081413265448000_bib103","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000351007","article-title":"2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors","volume":"2","author":"Beck-Peccoz","year":"2013","journal-title":"Eur Thyroid J"},{"key":"2026081413265448000_bib104","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2022.020601","article-title":"Artificial intelligence and thyroid disease management: considerations for thyroid function tests","volume":"32","author":"Gruson","year":"2022","journal-title":"Biochem Med"},{"key":"2026081413265448000_bib105","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/clinchem\/hvad141","article-title":"Generalizability of a machine learning model for improving utilization of parathyroid hormone-related peptide testing across multiple clinical centers","volume":"69","author":"Yang","year":"2023","journal-title":"Clin Chem"},{"key":"2026081413265448000_bib106","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1515\/cclm-2023-0571","article-title":"Toolkit for emerging technologies in laboratory medicine","volume":"61","author":"Greaves","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2026081413265448000_bib107","first-page":"105","article-title":"Interferences in immunoassay","volume":"25","author":"Tate","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"2026081413265448000_bib108","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-801401-1.00007-4","article-title":"Identifying and reducing potentially wrong immunoassay results even when plausible and \u201cnot-unreasonable\u201d","volume":"66","author":"Ismail","year":"2014","journal-title":"Adv Clin Chem"},{"key":"2026081413265448000_bib109","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: the macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026081413265448000_bib110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jalm\/jfz027","article-title":"A challenging case of falsely elevated free thyroid hormones","volume":"5","author":"Favresse","year":"2020","journal-title":"J Appl Lab Med"},{"key":"2026081413265448000_bib111","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2013.12.010","article-title":"Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients","volume":"429","author":"Lippi","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2026081413265448000_bib112","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/cclm-2016-1183","article-title":"High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin Chem Lab Med"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0011\/522459\/etj-26-0011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0011\/522459\/etj-26-0011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:55:44Z","timestamp":1786730144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/4\/ETJ260011\/77859\/2026-ETA-guideline-on-interference-in-immunoassay"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-26-0011","relation":{},"ISSN":["2235-0640","2235-0802"],"issn-type":[{"value":"2235-0640","type":"print"},{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"ETJ260011"}}